SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-160696
Filing Date
2024-06-13
Accepted
2024-06-13 16:06:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d839572ds3.htm S-3 166661
2 EX-5.1 d839572dex51.htm EX-5.1 11134
3 EX-23.2 d839572dex232.htm EX-23.2 1609
4 EX-FILING FEES d839572dexfilingfees.htm EX-FILING FEES 14447
5 GRAPHIC g839572g03a01.jpg GRAPHIC 32918
6 GRAPHIC g839572g36a70.jpg GRAPHIC 4025
  Complete submission text file 0001193125-24-160696.txt   245903
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280172 | Film No.: 241041250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)